MARKET

SLGL

SLGL

SOL GEL TECHNOLG
NASDAQ

Real-time Quotes | Nasdaq Last Sale

7.90
+0.11
+1.41%
Closed 16:00 08/04 EDT
OPEN
7.82
PREV CLOSE
7.79
HIGH
7.91
LOW
7.63
VOLUME
30.14K
TURNOVER
--
52 WEEK HIGH
21.00
52 WEEK LOW
5.00
MARKET CAP
181.51M
P/E (TTM)
-5.9542
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average SLGL stock price target is 22.80 with a high estimate of 33.00 and a low estimate of 16.00.

EPS

SLGL News

More
Sol-Gel Technologies to Report Second Quarter 2020 Financial Results on August 6, 2020
NESS ZIONA, Israel, July 29, 2020 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products
GlobeNewswire · 6d ago
Sol-Gel Technologies Says Partnered Generic Product Expected To Launch In Q2 Of 2021
  NESS ZIONA, Israel, July 28, 2020 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ:SLGL), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic
Benzinga · 07/28 11:10
Sol-Gel Technologies Partnered Generic Product Expected to Launch in the Second Quarter of 2021
NESS ZIONA, Israel, July 28, 2020 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin dis
GlobeNewswire · 07/28 11:05
Sol-Gel inks deal for three new generic product candidates with Perrigo
Seeking Alpha - Article · 06/29 12:38
Sol-Gel Technologies Announces Agreements with Perrigo Company for Three New Generic Product Candidates
Sol-Gel Technologies, Ltd. (SLGL), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, today announced that it has entered into collaborative
GlobeNewswire · 06/29 11:00
Sol-Gel to Present at Virtual BMO 2020 Prescriptions for Success Healthcare Conference
GlobeNewswire · 06/16 21:05
Sol-Gel Technologies Ltd. (SLGL): Hedge Funds In Wait-and-See Mode
Insider Monkey · 06/04 22:28
Sol-Gel to Present at Upcoming Healthcare Investor Conferences
NESS ZIONA, Israel, May 27, 2020 -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying,.
GlobeNewswire · 05/27 13:00

Industry

Biotechnology & Medical Research
+0.02%
Pharmaceuticals & Medical Research
-0.36%

Hot Stocks

Symbol
Price
%Change

About SLGL

Sol-Gel Technologies Ltd is a clinical-stage dermatology company. The Company is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The Company is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.
More

Webull offers kinds of Sol Gel Technologies Ltd stock information, including NASDAQ:SLGL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SLGL stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SLGL stock methods without spending real money on the virtual paper trading platform.